The findings may suggest that elevated IL-6 levels may be an indicator of further deterioration of gastric cancer patients or suggest that the tumor may metastasize, suggesting appropriate therapeutic measures to control the development of the disease, and the experimental results have some clinical guidance [35]. The gene discussed is IL6; the disease is neoplasm.